3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
311
Lymphoma
306
Lymphoma, Non-Hodgkin
227
Lymphoma, Large B-Cell, Diffuse
220
Lymphoma, Follicular
203
Leukemia, Lymphocytic, Chronic, B-Cell
166
Lymphoma, B-Cell
147
Recurrence
124
Burkitt Lymphoma
117
Lymphoma, Mantle-Cell
112
Leukemia, Myeloid, Acute
106
Leukemia
102
Hodgkin Disease
102
Multiple Myeloma
95
Lymphoma, B-Cell, Marginal Zone
87
Neoplasms
80
Myelodysplastic Syndromes
69
Lymphoma, T-Cell, Peripheral
62
Hematologic Neoplasms
61
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
58
Lymphoma, T-Cell
52
Lymphoma, T-Cell, Cutaneous
44
Waldenstrom Macroglobulinemia
41
Leukemia, Biphenotypic, Acute
35
Mycosis Fungoides
31
Lymphoproliferative Disorders
30
Leukemia, B-Cell
30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Breast Neoplasms
28
Myeloproliferative Disorders
26
Interventions
belimumab
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sjogren's Syndrome
×
Lymphoid
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled